LONDON PHARMA & CHEMICALS GROUP LTD
Get an alert when LONDON PHARMA & CHEMICALS GROUP LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£19m
+10.3% highest in 5 filed years
Net assets
£24m
+4.1% highest in 5 filed years
Employees
8
+14.3% vs 2024
Profit before tax
£1.1m
+205.4% first positive since 2021
Net assets
5-year trend · vs Industrials median
Accounts
5-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|---|---|
| Turnover | £2,054,397 | £597,080 | £661,820 | £587,012 | £687,188 | +17.1% | |
| Operating profit | £134,147 | -£357,383 | -£199,963 | -£908,537 | -£312,631 | +65.6% | |
| Profit before tax | £7,031,621 | -£505,581 | £979,106 | £344,661 | £1,052,530 | +205.4% | |
| Net profit | £7,010,979 | -£346,665 | £988,990 | £376,730 | £955,873 | +153.7% | |
| Cash | £7,654,464 | £11,793,278 | £16,406,039 | £17,428,081 | £19,214,826 | +10.3% | |
| Total assets less current liabilities | £20,143,298 | £19,637,717 | £25,240,671 | £25,550,246 | £26,400,080 | +3.3% | |
| Net assets | £17,584,520 | £16,978,774 | £22,719,505 | £23,096,235 | £24,052,108 | +4.1% | |
| Equity | — | £16,978,774 | £22,719,505 | £23,096,235 | £24,052,108 | +4.1% | |
| Average employees | 9 | 9 | 8 | 7 | 8 | +14.3% | |
| Wages | £215,634 | £403,625 | £612,688 | £643,195 | £554,105 | -13.9% | |
| Directors' remuneration | £106,381 | £191,912 | £428,814 | £466,373 | £364,826 | -21.8% | |
| Directors' pension contributions | — | — | £11,415 | £11,667 | £11,928 | +2.2% | |
| Highest paid director | — | — | £270,000 | £280,000 | £204,826 | -26.8% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-12-31 | 2021-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|---|
| Operating margin | 6.5% | -59.9% | -30.2% | -154.8% | -45.5% | |
| Net margin | — | -58.1% | 149.4% | 64.2% | 139.1% | |
| Return on capital employed | 0.7% | -1.8% | -0.8% | -3.6% | -1.2% | |
| Gearing (liabilities / total assets) | -3.4% | 8.0% | 34.7% | 34.8% | 36.0% | |
| Current ratio | — | — | 2.51x | 2.35x | 2.27x | |
| Interest cover | 5.93x | -51.85x | -0.65x | -2.27x | -0.85x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- LONDON PHARMA & CHEMICALS GROUP LTD 2011-07-04 → present
- LONDON PHARMA & CHEMICALS HOLDINGS LTD 2011-06-03 → 2011-07-04
- S & D PHARMA LIMITED 2003-02-11 → 2011-06-03
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Morris Palmer Limited
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“At the time of approving the financial statements, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting.”
Group structure
- LONDON PHARMA & CHEMICALS GROUP LTD · parent
- Chemgo AG 100%
- Chemgo SARL 100%
- F.I.T. Industries Limited 100%
- LPC Bulgaria OOD 60%
- ProTec Balkans EOOD 100%
- ProTec Botanica Ltd 85%
- ProTec Ingredia GmbH 80%
- ProTec Ingredia Limited 92%
- ProTec Nutra Limited 75%
- ProTec Polska Sp. z o.o. 99.6%
- S & D Pharma CZ, spol. s r.o. 100%
- S & D Pharma Logistics BG EOOD 100%
- S & D Pharma Limited 100%
- S & D Pharma SK s.r.o. 97%
- INB GmbH 100%
- F.I.T. Bulgaria OOD 85%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 7 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| L P C SECRETARIAL LIMITED | Corporate Secretary | 2011-05-17 | — | — |
| COUSINS, Kevin Mark | Director | 2023-07-06 | Jun 1969 | British |
| SANDLER, Jamie Andrew | Director | 2016-02-09 | Feb 1976 | British |
| STRAUS, Daniel Reuben | Director | 2003-02-11 | Apr 1972 | British |
Show 7 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| LONDON LAW SECRETARIAL LIMITED | Corporate Nominee Secretary | 2003-02-11 | 2003-02-11 |
| S & D SECRETARIES LIMITED | Corporate Secretary | 2003-02-14 | 2011-05-17 |
| EASTWOOD, Alan Edward | Director | 2012-01-06 | 2023-05-31 |
| LEEMANN, Christian | Director | 2012-01-06 | 2022-12-01 |
| NEMCOKOVA, Andrea | Director | 2007-06-01 | 2011-06-01 |
| STRAUS, Peter Frederick | Director | 2003-02-11 | 2011-12-03 |
| LONDON LAW SERVICES LIMITED | Corporate Nominee Director | 2003-02-11 | 2003-02-11 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| London Pharma & Chemicals Holdings Ltd | Corporate entity | Shares 75–100%, Voting 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 89 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-24 | AA | accounts | Accounts with accounts type full | |
| 2026-02-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-09-25 | AA | accounts | Accounts with accounts type full | |
| 2025-02-06 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-09-23 | AA | accounts | Accounts with accounts type full | |
| 2024-02-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-05 | AA | accounts | Accounts with accounts type full | |
| 2023-07-06 | AP01 | officers | Appoint person director company with name date | |
| 2023-05-31 | TM01 | officers | Termination director company with name termination date | |
| 2023-01-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-12-01 | TM01 | officers | Termination director company with name termination date | |
| 2022-09-15 | AA | accounts | Accounts with accounts type full | |
| 2022-02-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-27 | AA | accounts | Accounts with accounts type full | |
| 2021-05-25 | AA | accounts | Accounts with accounts type full | |
| 2021-02-26 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-02-12 | AA01 | accounts | Change account reference date company previous shortened | |
| 2020-02-26 | AA | accounts | Accounts with accounts type full | |
| 2020-02-06 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2019-02-28 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.